Article
Expanding the molecular spectrum of tenosynovial giant cell tumors
10 Nov 2022
Abstract excerpt
Background While great advances in clinical and pathological description of tenosynovial giant cell tumors (TGCT) have been made, TGCT molecular heterogeneity represents an ongoing challenge. The canonical oncogenic fusion CSF1::COL6A3 is not systematically observed, suggesting that other oncogenic mechanisms are involved in tumorigenesis. This study aims to explore by RNA sequencing a retrospective series of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
